High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?
높은 D 이량체와 낮은 글로벌 섬유소 용해는 COVID19 환자에서 공존합니다. 거기에서 무슨 일이 일어나고 있습니까?
Clinical Trial
[키워드] Adult patient
Adult patients
approval
calculated
characterized
clinical
clot
Coagulation
coagulation test
Coagulopathy
correlation
Course
COVID
COVID-19
COVID-19 infection
COVID-19 patient
COVID-19 patients
COVID19
D dimer
D-dimer
D-dimer level
D-dimer levels
detect
diagnosed with COVID-19
Disseminated intravascular coagulation
England
enrolled
ethics committee
fibrinogen
fibrinolysis
fibrinolytic
high mortality
hypercoagulable
Hypercoagulable state
Hypothesis
ICU
ICU admission
increase in
Inpatient
intravascular coagulation
Laboratory
Lancet
London
lung
Lungs
marker
median
morbidity
Mortality
normal range
occur
Organ failure
paradoxical
parameter
Patient
performed
pilot study
Platelet
Platelet count
retrospective cohort study
risk factor
Risk factors
sample collection
Sepsis
sepsis-induced coagulopathy
Septic shock
Sequential Organ Failure Assessment
Severe COVID-19 Infection
severely ill COVID-19 patients
SOFA
SOFA score
therapeutic anticoagulation
Thromboelastometry.
thromboembolic
Thromboembolic event
Thromboembolic events
Venous Thromboembolism
were excluded
while
with COVID-19
Wuhan
[DOI] 10.1007/s11239-020-02226-0 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1007/s11239-020-02226-0 PMC 바로가기 [Article Type] Clinical Trial